Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAUG.L Regulatory News (AUG)

  • There is currently no data for AUG

Placing

30 Sep 2009 07:00

RNS Number : 9148Z
Augean Plc
30 September 2009
 



30 September 2009

Augean plc ("Augean" or the "Company")

Fundraising of £13 million

Augean,  a major player in the UK' hazardous waste management market, is pleased to announce the placing of 34,210,522 new ordinary shares of 10 pence each ("New Ordinary Shares") at 38 pence per New Ordinary Share (the "Placing Price") with existing and new institutional investors to raise approximately £12.2 million, net of expenses (the "Fundraising"). The New Ordinary Shares represent 34.3 per cent. of the enlarged issued share capital of Augean. The Placing Price represents a discount of 17.4 per cent. to the Augean closing share price on 29 September. 

The new funds will primarily be used to reduce the Company's overall indebtedness and to provide additional working capital for Augean going forward as the Company enters new markets. 

Commenting on the successful Fundraising, Paul Blackler, Chief Executive of Augean said:

"We are pleased with and grateful for the strong support we have received from our existing shareholders and from new institutional investors. The support demonstrates the compelling growth prospects in the underlying Augean business."

"The new capital ensures that Augean is in a strong position to renegotiate banking facilities in due course and is well equipped to benefit from market recovery from the economic downturn."

Fundraising structure

The Fundraising, which has been underwritten by Singer Capital Markets Limited, has been effected by a conditional placing under a cash box structure. The New Ordinary Shares will, when issued and fully paid, rank pari passu in all respects with the existing issued ordinary shares of the Company. 

The Fundraising consists of two tranches, each conditional upon admission to trading on AIM, a market of the London Stock Exchange and upon the placing agreement having become unconditional and not being terminated (as regards that tranche). The first tranche consists of 21,052,626 New Ordinary Shares (the "First Tranche"), for which admission to trading has been sought, and it is expected that dealing in those New Ordinary Shares will commence on 6 October 2009. The second tranche consisting of 13,157,896 New Ordinary Shares (the "Second Tranche") is subject to shareholder approval which is being sought at a general meeting on or around 19 October, with admission expected on or around 22 October. A circular will be sent to shareholders shortly. 

Following the Fundraising, the Company will have 99,699,414 shares in issue.

  Directors' Participation 

The Directors have agreed to subscribe for a pro rata allocation in the Fundraising which aggregates to £0.1 million for 299,063 New Ordinary Shares at the Placing Price. The beneficial and non-beneficial interests of the Directors following the Fundraising are set out below:

 
 
Current interest
 
 
 
Interest after the Fundraising
Director
 
Number of Ordinary Shares
 
Percentage of Issued Ordinary Share Capital
 
Number of Ordinary Shares acquired in the Placing
 
Number of Ordinary Shares
 
Percentage of 
Issued Ordinary Share Capital
 
 
 
 
 
 
 
 
 
 
 
David Williams
 
480,000
 
0.73
 
250,744
 
730,744
 
0.73
Peter Southby
 
15,000
 
0.02
 
7,834
 
22,834
 
0.02
Roger McDowell
 
60,000
 
0.09
 
31,342
 
91,342
 
0.09
Andrew Bryce
 
7,500
 
0.01
 
3,919
 
11,419
 
0.01
Rory Macnamara
 
10,000
 
0.02
 
5,224
 
15,224
 
0.02

Company Projections 

Due to the lack of publicly available projections for the financial performance of Augean the management team of the Company has been presenting projections for the financial years 2010 and 2011 as part of the marketing process for the Fundraising. These summary projections are set out in the table below:

 
 
2010
 
 
2011
 
 
£'m
 
 
£'m
Net revenue
 
34.2
 
 
36.5
EBITDA
 
8.8
 
 
10.3
PBT
 
3.4
 
 
7.3
Free cash flow
 
2.2
 
 
4.7

 

Related party transaction 

JO Hambro, being the Company's second largest shareholder, is participating in the Fundraising which is deemed to be a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The Directors consider, having consulted with the Company's Nominated Adviser, Singer Capital Markets Limited, that the terms of the Fundraising are fair and reasonable insofar as the shareholders of the Company are concerned. 

  For further information please contact:

Augean plc 
Paul Blackler, Chief Executive
Peter Southby, Finance Director
 
01937 844 980
Singer Capital Markets Limited
Shaun Dobson 
Claes Spång
 
020 3205 7500
Financial Dynamics
Billy Clegg
Edward Westropp
 
020 7269 7157

Singer Capital Markets Limited, which is authorised and regulated by the Financial Services Authority in the United Kingdom, is acting exclusively for Augean and no one else in connection with matters described in this announcement and will not be responsible to anyone other than Augean for providing the protections afforded to clients of Singer Capital Markets Limited nor for providing advice in relation to matters described in this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZGGZLFLKGLZZ
Date   Source Headline
28th May 20211:37 pmRNSForm 8.3 - Augean plc
28th May 202111:56 amGNWForm 8.3 - [AUGEAN PLC - Opening Declaration - 27 05 2021] - (HHL)
28th May 202111:37 amRNSForm 8.3 - Augean Plc
28th May 202111:18 amRNSForm 8.5 (EPT/RI)
28th May 202111:11 amRNSForm 8.3 - [AUGEAN PLC]
28th May 202110:22 amRNSForm 8.5 (EPT/RI)
27th May 20214:05 pmRNSForm 8.3 - Augean plc
27th May 20213:28 pmEQSForm 8.3 - Maitland Institutional Services Limited: Augean plc
27th May 202112:05 pmRNSForm 8.3 - Augean Plc
27th May 20219:16 amRNSAnnouncement from Morgan Stanley Infrastructure
27th May 20219:05 amRNSSecond Price Monitoring Extn
27th May 20219:00 amRNSPrice Monitoring Extension
27th May 20217:00 amRNSStatement re Possible Offer
26th May 20217:00 amRNSAugean South Limited Assessment Notification
6th May 20217:00 amRNSAppointment of Joint Corporate Broker
22nd Apr 20215:59 pmRNSDirector/PDMR Shareholding
21st Apr 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th Mar 202112:30 pmRNSDirector/PDMR Shareholding
4th Mar 202112:30 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSFinal results for the year ended 31 December 2020
21st Jan 20219:28 amRNSHolding(s) in Company
18th Jan 20217:00 amRNSTrading Update
29th Dec 20207:00 amRNSExercise of options, PDMR dealing and TVR
21st Dec 202011:29 amRNSDirector/PDMR Shareholding
4th Dec 202011:03 amRNSExercise of options, PDMR dealing and TVR
26th Oct 20207:00 amRNSLandfill Tax Repayment of £1.6 million by HMRC
22nd Oct 20208:30 amRNSExercise of options, PDMR dealing and TVR
21st Sep 20207:00 amRNSInterim Report
1st Sep 202010:46 amRNSHolding(s) in Company
4th Aug 20202:00 pmRNSPrice Monitoring Extension
13th Jul 20204:46 pmRNSNotice of Interim Results
16th Jun 20207:00 amRNSResult of AGM and Board Appointment
5th Jun 202012:25 pmRNSUpdate on AGM
20th May 20209:17 amRNSExercise of Options, PDMR Dealing and TVR
18th May 20207:00 amRNSClaim for Repayment of Landfill Tax
6th May 20207:00 amRNSHolding(s) in Company
24th Mar 20204:41 pmRNSSecond Price Monitoring Extn
24th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202011:05 amRNSSecond Price Monitoring Extn
20th Mar 202011:00 amRNSPrice Monitoring Extension
18th Mar 20204:41 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20202:05 pmRNSSecond Price Monitoring Extn
18th Mar 20202:00 pmRNSPrice Monitoring Extension
2nd Mar 20207:00 amRNSHolding(s) in Company
26th Feb 20207:00 amRNSFinal results for the year ended 31 December 2019
13th Jan 20207:00 amRNSTrading Update
10th Dec 20197:00 amRNSBank Facilities and HMRC Landfill Tax Payment
3rd Dec 20197:00 amRNSVesting of LTIP
18th Oct 20197:00 amRNSAugean South Landfill Option

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.